Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM
· Real-Time Price · USD
3.14
-0.16 (-4.85%)
At close: Aug 19, 2025, 11:48 AM
-4.85% (1D)
| Bid | 3.14 |
| Market Cap | 2.24M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -25.33M |
| EPS (ttm) | 41.76 |
| PE Ratio (ttm) | 0.08 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3.16 |
| Volume | 16,557 |
| Avg. Volume (20D) | 1,674,283 |
| Open | 3.15 |
| Previous Close | 3.30 |
| Day's Range | 3.12 - 3.16 |
| 52-Week Range | 2.36 - 333.00 |
| Beta | 0.22 |
2 weeks ago
-6.85%
PBM stock has given up its prior gain. Psyence Bio...
Unlock content with
Pro Subscription
2 weeks ago
-6.85%
Psyence Biomedical shares are trading higher after the company announced it, along with PsyLabs, achieved a breakthrough in GMP-aligned high-purity ibogaine production.
2 months ago · newsfilecorp.com
Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025Investors, Entrepreneurs, and Industry Experts to Convene at the Premier Psychedelic Science Business Forum hosted by Multidisciplinary Association for Psychedelic Studies (MAPS) Denver, Colorado--(Ne...
2 months ago · newsfilecorp.com
Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing RequirementsNew York, New York--(Newsfile Corp. - June 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced that it has received formal notification from the Nasda...
